Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 6, 2017Industry's First MR-Conditional Directional DBS System with Stimulation Visualization
Industry's first MR-conditional directional DBS System with stimulation visualization
-
May 24, 2017Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference
Results from evaluation of real-world patients presented at American Thoracic Society International Conference
-
May 16, 2017
The first head-to-head pivotal study comparing two different TAVI platforms demonstrated the LOTUS™ Valve System’s superior efficacy.
-
May 16, 2017Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
BAcquisition expands company's structural heart portfolio; increases offerings for the treatment of patients with valvular heart disease
-
May 12, 2017Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017
Largest prospective study of the WATCHMAN device presented as late-breaking trial at Heart Rhythm 2017
-
May 12, 2017Analyses Evaluated the Impact of Ethnicity, Gender and Income on Cardiovascular Outcomes
Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes
-
May 11, 2017Late-Breaker Data Presented at Heart Rhythm 2017
Late-breaker data presented at Heart Rhythm 2017
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
New devices combine longest-lasting battery technology, therapy optimization and HeartLogic™ heart failure diagnostics
-
Apr 27, 2017
"We are pleased with our performance in the first quarter,” said CEO Mike Mahoney
-
Apr 18, 2017MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies
MADIT S-ICD trial to study EMBLEM™ MRI S-ICD System; part of pilot initiative to increase percentage of females enrolled in clinical studies
-
Mar 30, 2017Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally
Acquisition will expand treatments for patients with valvular heart disease and strengthen company's position in structural heart globally
-
Mar 16, 2017Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings
Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; potential for significant cost savings
-
Mar 9, 2017Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
Edwards found to infringe on Boston Scientific patents in Germany and U.K.
-
Feb 2, 2017
"Boston Scientific delivered excellent financial results in 2016,” said CEO Mike Mahoney
-
Dec 13, 2016
Acquisition will bring manufacturing assets and biologic tissue capabilities for use in Boston Scientific heart valve technologies.
- Dec 2, 2016$75M transaction enhances manufacturing expertise in structural heart
$75M transaction enhances manufacturing expertise in structural heart
Nov 22, 2016Acquisition Expands Endoscopy PortfolioAcquisition expands Boston Scientific endoscopy portfolio with a comprehensive array of gastrointestinal services and devices
- Nov 21, 2016
Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M....
-
Nov 16, 2016Late-Breaking Trial Data Presented at AHA Scientific Sessions Demonstrate Success of Alert to Predict Worsening Heart Failure
Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure Diagnostic Service to predict impending heart...
-
Nov 15, 2016Acquisition Advances Treatment Options for Women with Uterine Polyps
Boston Scientific (NYSE: BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a Salt Lake City based company that designs minimally invasive medical devices. The portfolio...
-
Nov 8, 2016Kidney Stone Retrieval Device Enables Physicians to Release and Capture Kidney Stones of Multiple Sizes
MARLBOROUGH, Mass., (Nov. 8, 2016) – Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launch of the Dakota™ Nitinol Stone Retrieval Device with OpenSure™...
-
Nov 3, 2016Technology to Improve Management of Gastrointestinal Diseases
Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue...
-
Nov 2, 2016Late-Breaking Trial Data Presented at TCT Scientific Sessions and Simultaneously Published in the Journal of the American College of Cardiology
Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial...
-
Nov 1, 2016The PLATINUM Diversity Study Provides Much Needed Data about Women and Minority Patients, Who are Under-represented in Cardiology Clinical Trials
As part of the commitment to support health equity for all patients, Boston Scientific Corporation (NYSE: BSX) sponsored the PLATINUM Diversity study to evaluate the clinical outcomes of the...
- Oct 26, 2016
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.105 billion during the third quarter ended September 30, 2016, compared to the company's guidance range for the quarter of $2.035 to...
